...improve survival for a form of lung cancer. The drug has been licensed by Genentech and Roche Holding AG of Switzerland. Abgenix Inc. up $3.00 at $17.70 Investors interpreted the good news for Tarceva as boosting prospects for this biotech's...
If you are the owner of this website, please log in for additional
information or contact us as soon as possible.
The Augusta Chronicle ©2013. All Rights Reserved.